Meghan Fitzgerald, Director at Roivant Sciences Ltd. (ROIV), sold 70,000 shares at $27.45 ($1.9M) on 2026-03-26, disclosed to the SEC on 2026-03-30.
Open-market sale of $1.9M ROIV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| THC | SELL | 2024-08-08 | $2.9M | — | Filing → |
| THC | SELL | 2021-09-20 | $884K | — | Filing → |
| THC | SELL | 2021-05-26 | $782K | — | Filing → |